2
BKAT STUDY EXAM
BKAT STUDY QUESTIONS WITH 100%
VERIFIED SOLUTION | UPDATED VERSION
2026-2027.
What to do first if patient has chest pain. -CORRECT ANS Rest!
ECG changes in an acute MI -CORRECT ANS ST elevation in 2 or more contiguous
leads. Ischemia d/t full thickness loss of muscle. EMERGENCY.
Inferior leads -CORRECT ANS II, III, aVF. RCA occlusion.
Septal leads -CORRECT ANS V1 & V2.
Anterior leads -CORRECT ANS V1 - V4. LAD lesion.
Lateral leads -CORRECT ANS V5, V6, I, and aVL. Circumflex lesion.
Cardiac enzymes -CORRECT ANS Troponins, CK-MB, and CK
Changes in CK -CORRECT ANS Rise: 3-6 hours
Peak: 24 hours
Normal: 3-4 days
Changes in CK-MB -CORRECT ANS Released after myocardial necrosis. Specific for
myocardial damage.
Rise: 3-12 hours
Peak: 24 hours
Normal: 2-3 days
Troponin I -CORRECT ANS Protein found in cardiac muscle. High sensitivity.
A+ GRADED 1
, 2
BKAT STUDY EXAM
Rise: 3-12 hours
Peak: 24 hours
Normal: 5-10 days
Troponin T -CORRECT ANS Protein found in cardiac muscle. High sensitivity.
Rise: 3-12 hours
Peak: 12-48 hours
Normal: 5-14 days
Common conditions that cause a murmur -CORRECT ANS Aortic dissection, aortic
regurgitation (both acute & chronic), mitral valve regurgitation (both acute &
chronic), mitral valve stenosis
Drugs to decrease afterload/SVR/PVR -CORRECT ANS (Arterial Dilators)
Nitroprusside, nitroglycerin, amrinone, alpha (Regitine) & Ca channel blockers
Drugs to increased afterload/SVR/PVR -CORRECT ANS (Vasopressors) Epinepherine,
norepinepherine, dopamine, neosynephrine
Drugs to decrease contractility/SVI -CORRECT ANS Beta blockers (atenolol,
metoprolol, propranolol, labetolol, esmolol) and Ca channel blockers
Drugs to increase contractility/SVI -CORRECT ANS Positive inotropes, dobutamine,
dopamine, milrinone, and digoxin
Drugs to decrease preload/CVP/PAWP -CORRECT ANS Venous Dilators -
Nitroglycerin, nitroprusside, amrinone, alpha & Ca channel blockers
Diuretics - Furosemide, bumex, mannitol
Drugs to increase preload/CVP/PAWP -CORRECT ANS Volume - Colloid, crystalloids,
blood, hetastarch
Dysrhythmia control - antirhythmics, pacemaker, AICD
A+ GRADED 2
, 2
BKAT STUDY EXAM
Complications when using thrombolytics -CORRECT ANS Allergic reaction,
bleeding/hemorrhage, stroke
Failure to capture -CORRECT ANS Pacer delivers a stimulus at the appropriate time
but no depolarization occurs. No P or QRS wave after pacer spike.
Failure to fire/pace -CORRECT ANS No pacer spikes seen
Failure to sense -CORRECT ANS Pacemaker does not detects heart's intrinsic
activity or interprets noncardiac activity as intrinsic activity. Spikes in inappropriate
times.
Normal PR -CORRECT ANS 0.12 - 0.20
Normal QRS -CORRECT ANS 0.04-0.10
Normal QT -CORRECT ANS Less than 0.48. Varies by age, HR, and gender.
Vasopressors -CORRECT ANS Epinepherine, norepinepherine, dopamine,
phenylephrine/neosynephrine, vasopressin/pitressin, milrinone/Primacor,
dobutamine/Dobutrex
Indication for dopamine/Intropin -CORRECT ANS Acts on SNS to increased HR and
BP. Indicated for hypotension, low CO, decreased renal blood flow. Use if patient is
bradycardic.
Doses of dopamine -CORRECT ANS Low: 0.5-2 mcg/kg/min (dopaminergic)
Intermediate: 2-10 mcg/kg/min (beta receptors, increases CO)
High: over 10 mcg/kg/min (alpha receptors, vasoconstrict)
A+ GRADED 3
BKAT STUDY EXAM
BKAT STUDY QUESTIONS WITH 100%
VERIFIED SOLUTION | UPDATED VERSION
2026-2027.
What to do first if patient has chest pain. -CORRECT ANS Rest!
ECG changes in an acute MI -CORRECT ANS ST elevation in 2 or more contiguous
leads. Ischemia d/t full thickness loss of muscle. EMERGENCY.
Inferior leads -CORRECT ANS II, III, aVF. RCA occlusion.
Septal leads -CORRECT ANS V1 & V2.
Anterior leads -CORRECT ANS V1 - V4. LAD lesion.
Lateral leads -CORRECT ANS V5, V6, I, and aVL. Circumflex lesion.
Cardiac enzymes -CORRECT ANS Troponins, CK-MB, and CK
Changes in CK -CORRECT ANS Rise: 3-6 hours
Peak: 24 hours
Normal: 3-4 days
Changes in CK-MB -CORRECT ANS Released after myocardial necrosis. Specific for
myocardial damage.
Rise: 3-12 hours
Peak: 24 hours
Normal: 2-3 days
Troponin I -CORRECT ANS Protein found in cardiac muscle. High sensitivity.
A+ GRADED 1
, 2
BKAT STUDY EXAM
Rise: 3-12 hours
Peak: 24 hours
Normal: 5-10 days
Troponin T -CORRECT ANS Protein found in cardiac muscle. High sensitivity.
Rise: 3-12 hours
Peak: 12-48 hours
Normal: 5-14 days
Common conditions that cause a murmur -CORRECT ANS Aortic dissection, aortic
regurgitation (both acute & chronic), mitral valve regurgitation (both acute &
chronic), mitral valve stenosis
Drugs to decrease afterload/SVR/PVR -CORRECT ANS (Arterial Dilators)
Nitroprusside, nitroglycerin, amrinone, alpha (Regitine) & Ca channel blockers
Drugs to increased afterload/SVR/PVR -CORRECT ANS (Vasopressors) Epinepherine,
norepinepherine, dopamine, neosynephrine
Drugs to decrease contractility/SVI -CORRECT ANS Beta blockers (atenolol,
metoprolol, propranolol, labetolol, esmolol) and Ca channel blockers
Drugs to increase contractility/SVI -CORRECT ANS Positive inotropes, dobutamine,
dopamine, milrinone, and digoxin
Drugs to decrease preload/CVP/PAWP -CORRECT ANS Venous Dilators -
Nitroglycerin, nitroprusside, amrinone, alpha & Ca channel blockers
Diuretics - Furosemide, bumex, mannitol
Drugs to increase preload/CVP/PAWP -CORRECT ANS Volume - Colloid, crystalloids,
blood, hetastarch
Dysrhythmia control - antirhythmics, pacemaker, AICD
A+ GRADED 2
, 2
BKAT STUDY EXAM
Complications when using thrombolytics -CORRECT ANS Allergic reaction,
bleeding/hemorrhage, stroke
Failure to capture -CORRECT ANS Pacer delivers a stimulus at the appropriate time
but no depolarization occurs. No P or QRS wave after pacer spike.
Failure to fire/pace -CORRECT ANS No pacer spikes seen
Failure to sense -CORRECT ANS Pacemaker does not detects heart's intrinsic
activity or interprets noncardiac activity as intrinsic activity. Spikes in inappropriate
times.
Normal PR -CORRECT ANS 0.12 - 0.20
Normal QRS -CORRECT ANS 0.04-0.10
Normal QT -CORRECT ANS Less than 0.48. Varies by age, HR, and gender.
Vasopressors -CORRECT ANS Epinepherine, norepinepherine, dopamine,
phenylephrine/neosynephrine, vasopressin/pitressin, milrinone/Primacor,
dobutamine/Dobutrex
Indication for dopamine/Intropin -CORRECT ANS Acts on SNS to increased HR and
BP. Indicated for hypotension, low CO, decreased renal blood flow. Use if patient is
bradycardic.
Doses of dopamine -CORRECT ANS Low: 0.5-2 mcg/kg/min (dopaminergic)
Intermediate: 2-10 mcg/kg/min (beta receptors, increases CO)
High: over 10 mcg/kg/min (alpha receptors, vasoconstrict)
A+ GRADED 3
